Login

From the Helm: Lindsay Partridge on Brickworks' Growth and Dividend Success | Lindsay Partridge - CEO of brickworks ltd 00:10:00

Share On Facebook Share On Twitter

Lindsay Partridge is the CEO of brickworks ltd

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
AAK AB Q2 2023 Report: CEO Johan Westman’s Analysis | Johan Westman, CEO , AAK AB.
00:10:00
Maulik Patel, Executive Director of Sahajanand Laser Technology Ltd, discusses IMTEX FORMING 2024.
00:10:00
Insights and updates from the leader of PetVivo Holdings.|Mr. Lai has been a director and senior executive officer of PetVivo Holdings.
00:10:00
DST Built a Global Portfolio of Tech Giants|John Lindfors,Cofounder And Managing Partner, DST Global
00:00:00
Manjinder Kandola, M.D.
00:10:00
A Discussion with Einat Wilf on Israel's Offensive War and the Integrated War Machine of Hamas|Einat Wilf, Professor, Georgetown University
00:10:00
It takes an extended network to find the best startups for investment |Herston Powers,General Partner, 1982 Ventures
00:10:00
startup founders and aspiring entrepreneurs learn, connect, and build their businesses.|Mark Suster,General Partner,Upfront Ventures
00:10:00
"This production by Finwire.tv, in collaboration with the company, encourages subscribing for more engaging corporate films, interviews, and presentations, with a disclaimer that no members of the production team owned shares in the company at the time of
00:10:00
Governance Risk at CIO Choice 2019 of ARCON | Matthew Jeffs, CHIEF EXECUTIVE OFFICER, Arcontech Group PLCARC:LSE
00:10:00
Interview with Hans Wallenstam, CEO of Wallenstam | Hans Wallenstam, CEO, Wallenstam AB.
00:10:00
Fostering Sustainable Impact: Ardian's Commitment to Equity and Climate Action | Dominique Senequier, President, Ardian.

© 2026 Nehu